IMTX
Immatics NV
NASDAQ · Healthcare · Biotechnology · DE
$8.62
−2.27%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$0.50
- Revenue estimate
- $12.5M
Latest reported
- Last report date
- Aug 18, 2026
- EPS actual
- -$0.53
- EPS estimate
- -$0.47
- Revenue actual
- $11.9M
- Revenue estimate
- $12.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.3%
- Revenue beats (12Q)
- 6
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 18, 2026 | -$0.47 | -$0.53 | Miss -11.64% | $11.9M |
| May 12, 2026 | -$0.42 | -$0.50 | Miss -19.05% | $8.8M |
| Mar 5, 2026 | -$0.48 | -$0.34 | Beat 29.17% | $22.3M |
| Nov 17, 2025 | -$0.44 | -$0.49 | Miss -11.53% | $6.1M |
| Aug 13, 2025 | -$0.38 | -$0.66 | Miss -73.68% | $5.6M |
| Mar 27, 2025 | -$0.33 | $0.48 | Beat 245.45% | $58.2M |
| Nov 18, 2024 | -$0.27 | -$0.12 | Beat 55.56% | $55.4M |
| Aug 13, 2024 | -$0.35 | -$0.18 | Beat 48.57% | $20.2M |
| Mar 21, 2024 | -$0.41 | -$0.32 | Beat 21.95% | $17.5M |
| Nov 14, 2023 | -$0.42 | -$0.35 | Beat 16.67% | $6.3M |
| Aug 17, 2023 | -$0.34 | -$0.35 | Miss -2.94% | $24.4M |
| May 16, 2023 | -$0.35 | -$0.28 | Beat 20.00% | $10.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026